US Patent Issued to ELECTROPHORETICS on Sept. 23 for "Biomolecules involved in Alzheimer's disease" (British Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,871, issued on Sept. 23, was assigned to ELECTROPHORETICS Ltd. (Cobham, Great Britain).

"Biomolecules involved in Alzheimer's disease" was invented by Ian Hugo Pike (Cobham, Great Britain), Malcolm Andrew Ward (Cobham, Great Britain), Claire Louise Russell (Cobham, Great Britain) and Vikram Mitra (Cobham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to panels of biomarkers including proteins phosphatase 1 regulatory subunit 14A and/or 2',3'-cyclic-nucleotide 3'-phosphodiesterase and/or phosphorylated tau or fragments thereof and methods using thereof for diagnosing, staging, treating and assessing the response ...